Addex Therapeutics Statistics
Total Valuation
SWX:ADXN has a market cap or net worth of CHF 5.94 million. The enterprise value is 3.15 million.
Market Cap | 5.94M |
Enterprise Value | 3.15M |
Important Dates
The last earnings date was Monday, September 1, 2025.
Earnings Date | Sep 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:ADXN has 98.35 million shares outstanding. The number of shares has increased by 17.91% in one year.
Current Share Class | 98.35M |
Shares Outstanding | 98.35M |
Shares Change (YoY) | +17.91% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 26.71% |
Owned by Institutions (%) | 2.46% |
Float | 26.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 35.51 |
PB Ratio | 0.82 |
P/TBV Ratio | 0.82 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.52 |
EV / Sales | 18.86 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.19 |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.31 |
Quick Ratio | 2.03 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | -1,161.67 |
Financial Efficiency
Return on equity (ROE) is -61.91% and return on invested capital (ROIC) is -15.09%.
Return on Equity (ROE) | -61.91% |
Return on Assets (ROA) | -13.55% |
Return on Invested Capital (ROIC) | -15.09% |
Return on Capital Employed (ROCE) | -32.72% |
Revenue Per Employee | 83,643 |
Profits Per Employee | -3.02M |
Employee Count | 2 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.03% in the last 52 weeks. The beta is 1.77, so SWX:ADXN's price volatility has been higher than the market average.
Beta (5Y) | 1.77 |
52-Week Price Change | -2.03% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 58.34 |
Average Volume (20 Days) | 1,133,622 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:ADXN had revenue of CHF 167,285 and -6.05 million in losses. Loss per share was -0.06.
Revenue | 167,285 |
Gross Profit | -103,578 |
Operating Income | -2.41M |
Pretax Income | -6.15M |
Net Income | -6.05M |
EBITDA | -2.33M |
EBIT | -2.41M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 2.30 million in cash and 38,387 in debt, giving a net cash position of 2.26 million or 0.02 per share.
Cash & Cash Equivalents | 2.30M |
Total Debt | 38,387 |
Net Cash | 2.26M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 7.21M |
Book Value Per Share | 0.08 |
Working Capital | 1.51M |
Cash Flow
In the last 12 months, operating cash flow was -1.44 million and capital expenditures -1,273, giving a free cash flow of -1.44 million.
Operating Cash Flow | -1.44M |
Capital Expenditures | -1,273 |
Free Cash Flow | -1.44M |
FCF Per Share | -0.01 |
Margins
Gross Margin | -61.92% |
Operating Margin | -1,438.85% |
Pretax Margin | -3,675.87% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SWX:ADXN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.91% |
Shareholder Yield | n/a |
Earnings Yield | -101.84% |
FCF Yield | -24.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |